ACR Responds to NRC Radiation Safety Proposed Rule
ACR supported continued use of ALARA-based radiation safety programs and offered recommendations on nuclear medicine patient release changes.
Read moreThe Centers for Disease Control and Prevention (CDC) alerted healthcare facilities about non-sterile ultrasound gel products — MediChoice® [lots: 240302 and 240306] and ClearImage® [lots: 230221, 230256, 240227, and 240230] — contaminated with an environmental bacterium, Paraburkholderia fungorum. The CDC confirmed 40 cases of P. fungorum in patients who were exposed to contaminated non-sterile ultrasound gel products in four states.
The agency urges healthcare providers to ensure patient safety by only using single-use ultrasound gels that are labeled “sterile” before and during percutaneous procedures. The full alert and more information is on the CDC website.
ACR Responds to NRC Radiation Safety Proposed Rule
ACR supported continued use of ALARA-based radiation safety programs and offered recommendations on nuclear medicine patient release changes.
Read moreACR Urges CMS to Withdraw E/M Payment Reduction Proposal
ACR joins national physician groups opposing a CMS Medicare payment proposal that could reduce E/M reimbursements.
Read moreNew Draft Measures for 2027 MIPS
Explore ACR’s proposed 2027 MIPS measures and QCDR updates designed to improve radiology quality, reporting accuracy and patient outcomes.
Read more